604 related articles for article (PubMed ID: 23445354)
1. Changes in sexual functioning in women after neuromodulation for voiding dysfunction.
Yih JM; Killinger KA; Boura JA; Peters KM
J Sex Med; 2013 Oct; 10(10):2477-83. PubMed ID: 23445354
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Abdominal Contouring with Monsplasty on Sexual Function and Urogenital Distress in Women Following Massive Weight Loss.
Bykowski MR; Rubin JP; Gusenoff JA
Aesthet Surg J; 2017 Jan; 37(1):63-70. PubMed ID: 27780812
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous Tibial Nerve Stimulation Improves Female Sexual Function in Women With Overactive Bladder Syndrome.
Musco S; Serati M; Lombardi G; Lumi E; Parisi AI; Del Popolo G; Finazzi Agrò E
J Sex Med; 2016 Feb; 13(2):238-42. PubMed ID: 26803455
[TBL] [Abstract][Full Text] [Related]
4. Female Sexual Dysfunction in the Late Postpartum Period Among Women with Previous Gestational Diabetes Mellitus.
Sargin MA; Yassa M; Taymur BD; Taymur B; Akca G; Tug N
J Coll Physicians Surg Pak; 2017 Apr; 27(4):203-208. PubMed ID: 28492147
[TBL] [Abstract][Full Text] [Related]
5. Secondary changes in bowel function after successful treatment of voiding symptoms with neuromodulation.
Killinger KA; Kangas JR; Wolfert C; Boura JA; Peters KM
Neurourol Urodyn; 2011 Jan; 30(1):133-7. PubMed ID: 20928914
[TBL] [Abstract][Full Text] [Related]
6. Impact of sacral neuromodulation on female sexual function and his correlation with clinical outcome and quality of life indexes: a monocentric experience.
Signorello D; Seitz CC; Berner L; Trenti E; Martini T; Galantini A; Lusuardi L; Lodde M; Pycha A
J Sex Med; 2011 Apr; 8(4):1147-55. PubMed ID: 21269397
[TBL] [Abstract][Full Text] [Related]
7. Clinical female sexual outcome after sacral neuromodulation implant for lower urinary tract symptom (LUTS).
Lombardi G; Mondaini N; Macchiarella A; Cilotti A; Del Popolo G
J Sex Med; 2008 Jun; 5(6):1411-7. PubMed ID: 18373528
[TBL] [Abstract][Full Text] [Related]
8. Is sensory testing during lead placement crucial for achieving positive outcomes after sacral neuromodulation?
Peters KM; Killinger KA; Boura JA
Neurourol Urodyn; 2011 Nov; 30(8):1489-92. PubMed ID: 21674596
[TBL] [Abstract][Full Text] [Related]
9. Effect of vaginal electrical stimulation on female sexual functions: a randomized study.
Aydın S; Arıoğlu Aydın Ç; Batmaz G; Dansuk R
J Sex Med; 2015 Feb; 12(2):463-9. PubMed ID: 25470078
[TBL] [Abstract][Full Text] [Related]
10. The impact of lower urinary tract symptoms and urinary incontinence on female sexual dysfunction using a validated instrument.
Cohen BL; Barboglio P; Gousse A
J Sex Med; 2008 Jun; 5(6):1418-23. PubMed ID: 18355169
[TBL] [Abstract][Full Text] [Related]
11. Sexual response in patients treated with sacral neuromodulation for lower urinary tract symptoms or fecal incontinence.
van Voskuilen AC; Oerlemans DJ; Gielen N; Lansen-Koch SM; Weil EH; van Lankveld JJ; van den Hombergh U; Baeten CG; van Kerrenbroeck PE
Urol Int; 2012; 88(4):423-30. PubMed ID: 22538447
[TBL] [Abstract][Full Text] [Related]
12. Female sexual function and activity following cystectomy and continent urinary tract diversion for benign indications: a clinical pilot study and review of literature.
Elzevier HW; Nieuwkamer BB; Pelger RC; Lycklama à Nijeholt AA
J Sex Med; 2007 Mar; 4(2):406-16. PubMed ID: 17367436
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of the Female Sexual Function Index adaptation for breast cancer patients (FSFI-BC).
Bartula I; Sherman KA
Breast Cancer Res Treat; 2015 Aug; 152(3):477-88. PubMed ID: 26198992
[TBL] [Abstract][Full Text] [Related]
14. Different Characteristics of the Female Sexual Function Index in a Sample of Sexually Active and Inactive Women.
Hevesi K; Mészáros V; Kövi Z; Márki G; Szabó M
J Sex Med; 2017 Sep; 14(9):1133-1141. PubMed ID: 28859872
[TBL] [Abstract][Full Text] [Related]
15. Adding a sexual dysfunction domain to UPOINT system improves association with symptoms in women with interstitial cystitis and bladder pain syndrome.
Liu B; Su M; Zhan H; Yang F; Li W; Zhou X
Urology; 2014 Dec; 84(6):1308-13. PubMed ID: 25312548
[TBL] [Abstract][Full Text] [Related]
16. Effects of sacral neuromodulation on female sexual function.
Pauls RN; Marinkovic SP; Silva WA; Rooney CM; Kleeman SD; Karram MM
Int Urogynecol J Pelvic Floor Dysfunct; 2007 Apr; 18(4):391-5. PubMed ID: 16868656
[TBL] [Abstract][Full Text] [Related]
17. Does the Severity of Overactive Bladder Symptoms Correlate With Risk for Female Sexual Dysfunction?
Juliato CRT; Melotti IGR; Junior LCS; Britto LGO; Riccetto CLZ
J Sex Med; 2017 Jul; 14(7):904-909. PubMed ID: 28622875
[TBL] [Abstract][Full Text] [Related]
18. Sexual dysfunction in women with hyperprolactinemia: a pilot study report.
Kadioglu P; Yalin AS; Tiryakioglu O; Gazioglu N; Oral G; Sanli O; Onem K; Kadioglu A
J Urol; 2005 Nov; 174(5):1921-5. PubMed ID: 16217346
[TBL] [Abstract][Full Text] [Related]
19. Sexual function remains persistently low in women after treatment for colorectal cancer and anal squamous cell carcinoma.
Savoie MB; Paciorek A; Van Loon K; Anwar M; Atreya CE; Johnson PC; Kenfield SA; Laffan A; Levin AO; Smith JF; Stanfield D; Venook A; Zhang L; Van Blarigan EL; Rowen T
J Sex Med; 2023 Mar; 20(4):439-446. PubMed ID: 36805959
[TBL] [Abstract][Full Text] [Related]
20. A Survey of Female Sexual Functioning in the General Dutch Population.
Lammerink EAG; de Bock GH; Pascal A; van Beek AP; van den Bergh ACM; Sattler MGA; Mourits MJE
J Sex Med; 2017 Jul; 14(7):937-949. PubMed ID: 28673436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
